43
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Assessing clinicopathological correlation in chronic traumatic encephalopathy: rationale and methods for the UNITE study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Chronic traumatic encephalopathy (CTE) is a progressive neurodegeneration associated with repetitive head impacts. Understanding Neurologic Injury and Traumatic Encephalopathy (UNITE) is a U01 project recently funded by the National Institute of Neurological Disorders and Stroke and the National Institute of Biomedical Imaging and Bioengineering. The goal of the UNITE project is to examine the neuropathology and clinical presentation of brain donors designated as “at risk” for the development of CTE based on prior athletic or military exposure. Here, we present the rationale and methodology for UNITE.

          Methods

          Over the course of 4 years, we will analyze the brains and spinal cords of 300 deceased subjects who had a history of repetitive head impacts sustained during participation in contact sports at the professional or collegiate level or during military service. Clinical data are collected through medical record review and retrospective structured and unstructured family interviews conducted by a behavioral neurologist or neuropsychologist. Blinded to the clinical data, a neuropathologist conducts a comprehensive assessment for neurodegenerative disease, including CTE, using published criteria. At a clinicopathological conference, a panel of physicians and neuropsychologists, blinded to the neuropathological data, reaches a clinical consensus diagnosis using published criteria, including proposed clinical research criteria for CTE.

          Results

          We will investigate the validity of these clinical criteria and sources of error by using recently validated neuropathological criteria as a gold standard for CTE diagnosis. We also will use statistical modeling to identify diagnostic features that best predict CTE pathology.

          Conclusions

          The UNITE study is a novel and methodologically rigorous means of assessing clinicopathological correlation in CTE. Our findings will be critical for developing future iterations of CTE clinical diagnostic criteria.

          Related collections

          Most cited references88

          • Record: found
          • Abstract: found
          • Article: found

          The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

          The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia. The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or in clinical trial studies who would have these tools available. We present criteria for all-cause dementia and for AD dementia. We retained the general framework of probable AD dementia from the 1984 criteria. On the basis of the past 27 years of experience, we made several changes in the clinical criteria for the diagnosis. We also retained the term possible AD dementia, but redefined it in a manner more focused than before. Biomarker evidence was also integrated into the diagnostic formulations for probable and possible AD dementia for use in research settings. The core clinical criteria for AD dementia will continue to be the cornerstone of the diagnosis in clinical practice, but biomarker evidence is expected to enhance the pathophysiological specificity of the diagnosis of AD dementia. Much work lies ahead for validating the biomarker diagnosis of AD dementia. Copyright © 2011. Published by Elsevier Inc.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Neuropathological stageing of Alzheimer-related changes

            Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes. The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages. Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads. The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another. Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages. The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II). The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex. In addition, there was mild involvement of the first Ammon's horn sector. The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas. The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

              The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of developing criteria for the symptomatic predementia phase of Alzheimer's disease (AD), referred to in this article as mild cognitive impairment due to AD. The workgroup developed the following two sets of criteria: (1) core clinical criteria that could be used by healthcare providers without access to advanced imaging techniques or cerebrospinal fluid analysis, and (2) research criteria that could be used in clinical research settings, including clinical trials. The second set of criteria incorporate the use of biomarkers based on imaging and cerebrospinal fluid measures. The final set of criteria for mild cognitive impairment due to AD has four levels of certainty, depending on the presence and nature of the biomarker findings. Considerable work is needed to validate the criteria that use biomarkers and to standardize biomarker analysis for use in community settings. Copyright © 2011 The Alzheimer's Association. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                jessemez@bu.edu
                tsolom@bu.edu
                ddanesh@bu.edu
                lmurphy2@bu.edu
                pkiernan@bu.edu
                valmont@bu.edu
                jkriegel@bu.edu
                babdolmo@bu.edu
                bfry@bu.edu
                kbabcock@bu.edu
                jadams2@bu.edu
                abourlas@bu.edu
                zpapadopoulos@colgate.edu
                lmchale@sportslegacy.org
                ardaugh@bu.edu
                brmartin@bu.edu
                dixon@bu.edu
                nowinski@sportslegacy.org
                chaisson@bu.edu
                valvarez@bu.edu
                yorghos@bu.edu
                tdstein@bu.edu
                lgold@bu.edu
                dkatz@bu.edu
                nkowall@bu.edu
                rcantu@emersonhosp.org
                bobstern@bu.edu
                617-414-1188 , amckee@bu.edu
                Journal
                Alzheimers Res Ther
                Alzheimers Res Ther
                Alzheimer's Research & Therapy
                BioMed Central (London )
                1758-9193
                12 October 2015
                12 October 2015
                2015
                : 7
                : 62
                Affiliations
                [ ]Alzheimer’s Disease Center, Boston University School of Medicine, 72 East Concord Street, B-7800, Boston, MA 02118 USA
                [ ]Department of Neurology, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118 USA
                [ ]Sports Legacy Institute, 230 Second Avenue, Waltham, MA 02451 USA
                [ ]Department of Anatomy and Neurobiology, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118 USA
                [ ]Data Coordinating Center, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118 USA
                [ ]VA Boston Healthcare System, U.S. Department of Veterans Affairs, 150 South Huntington Street, Jamaica Plain, MA 02130 USA
                [ ]Department of Veterans Affairs Medical Center, 200 Springs Road, Bedford, MA 01730 USA
                [ ]Department of Pathology, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118 USA
                [ ]Department of Biostatistics, Boston University School of Public Health, 72 East Concord Street, Boston, MA 02118 USA
                [ ]Braintree Rehabilitation Hospital, 250 Pond Street, Braintree, MA 02184 USA
                [ ]Department of Pathology and Laboratory Medicine, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118 USA
                [ ]Department of Neurosurgery, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118 USA
                [ ]Department of Neurosurgery, Emerson Hospital, 133 Old Road to Nine Acre Corner, Concord, MA 01742 USA
                Article
                148
                10.1186/s13195-015-0148-8
                4601147
                26455775
                6c575c03-27ee-41e7-ae36-72690b967a34
                © Mez et al. 2015

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 3 July 2015
                : 15 September 2015
                Categories
                Research
                Custom metadata
                © The Author(s) 2015

                Neurology
                Neurology

                Comments

                Comment on this article